To include your compound in the COVID-19 Resource Center, submit it here.

Scyllo-inositol: Phase II started

Elan began the double-blind, placebo-controlled, U.S. Phase II ELND005-BPD201 trial to evaluate oral ELND005 as an adjunctive

Read the full 178 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE